Prevention of Post-ERCP Pancreatitis

被引：21
作者：
Jennifer Maranki
Paul Yeaton
机构：
[1] Temple University School of Medicine,
[2] Carilion Virginia Tech School of Medicine,undefined
来源：
Current Gastroenterology Reports | 2013年 / 15卷 / 11期
关键词：
Post-ERCP pancreatitis; ERCP; Pancreatitis; Complications; Prevention; Endoscopic retrograde cholangiopancreatography; Management; Stents; Indomethacin;
D O I：
10.1007/s11894-013-0352-2
中图分类号：
学科分类号：
摘要：
Pancreatitis is one of the most common complications of endoscopic retrograde cholangiopancreatography (ERCP). A variety of patient-related and procedure-related factors have been identified to risk-stratify patients. Several measures can be undertaken in order to decrease the risk of post-ERCP pancreatitis in high-risk groups. These measures include pancreatic duct stenting and rectal indomethacin, amongst others.
引用
收藏
相关论文
共 223 条
[61]  
Kim JH(2010)A meta-analysis for the effect of prophylactic GTN on the incidence of post-ERCP pancreatitis and on the successful rate of cannulation of bile ducts BMC Gastroenterol 10 85-7
[62]  
Hwang JC(2010)Nitroglycerin in the prevention of post-ERCP pancreatitis: a meta-analysis Dig Dis Sci 55 1-186
[63]  
Paspatis GA(2011)Nafamostat mesilate for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a prospective, randomized, double-blind, controlled trial Pancreas 40 181-987
[64]  
Konstantinidis K(2007)Efficacy of postprocedure administration of gabexate mesylate in the prevention of post-ERCP pancreatitis: a randomized, controlled, multicenter study Gastrointest Endosc 65 982-1219
[65]  
Tribonias G(2011)Is high-dose nafamostat mesilate effective for the prevention of post-ERCP pancreatitis, especially in high-risk patients? Pancreas 40 1215-706
[66]  
Cheung J(2011)Protease inhibitors for preventing complications associated with ERCP: an updated meta-analysis Gastrointest Endosc 73 700-261
[67]  
Tsoi KK(2012)The use of gabexate mesylate and ulinastatin for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis Gut Liver 6 256-539
[68]  
Quan WL(2011)Intravenous synthetic secretin reduces the incidence of pancreatitis induced by endoscopic retrograde cholangiopancreatography Pancreas 40 533-246
[69]  
Matsubayashi H(2008)Prophylactic octreotide administration does not prevent post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials Pancreas 37 241-632
[70]  
Fukutomi A(2007)Prophylactic administration of somatostatin or gabexate does not prevent pancreatitis after ERCP: an updated meta-analysis Gastrointest Endosc 65 624-59
234567891011